SCHEMBL6587409

SCHEMBL6587409

CCOC(=O)N1c2ccc(C)cc2C(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)CC1C

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6587402 1.00 CETP (0.73) CETP
SCHEMBL6038720 0.94 CETP (0.82) CETP
SCHEMBL993404 0.94 CETP (0.82) CETP
SCHEMBL6587881 0.93 CETP (0.73) CETP
SCHEMBL1077543 0.93 CETP (0.73) CETP
SCHEMBL7722303 0.92 CETP (0.72) CETP
SCHEMBL7722305 0.92 CETP (0.72) CETP
SCHEMBL993557 0.92 CETP (0.71) CETP
SCHEMBL6589544 0.92 CETP (0.76) CETP
SCHEMBL6585798 0.92 CETP (0.71) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1114033-B1 4-CARBOXYAMINO-2-METHYL-1,2,3,4-TETRAHYDROQUINOLINES AS CETP INHIBITORS PFIZER PROD INC (US) 2004-09-29 EP disclosed
US-6395751-B1 SYNERGISTIC MIXTURE; ANTICHOLESTEROL AGENTS PFIZER INC. 2002-05-28 US disclosed
US-6147090-A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS USED TO TREAT DISEASES WHICH ARE EXACERBATED BY LOW LEVELS OF HDL CHOLESTEROL AND/OR HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES, SUCH AS ATHEROSCLEROSIS AND CARDIOVASCULAR PFIZER INC. (US) 2000-11-14 US disclosed